8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Feb 1, 2011)

Filed February 1, 2011For Securities:BIIB

Summary

Biogen Idec Inc. (BIIB) filed an 8-K on February 1, 2011, to report its financial and operational results for the full year and fourth quarter ended December 31, 2010. This filing primarily serves to furnish a press release detailing these results, which is incorporated by reference. Investors should refer to the press release for specific financial figures, performance metrics, and any forward-looking statements made by the company. The 8-K itself does not contain the detailed financial data but directs stakeholders to the press release for comprehensive information on the company's performance during the specified periods. This includes details on revenue, profitability, and any significant business developments that may have impacted the company's financial condition. Investors looking for in-depth analysis of Biogen Idec's financial standing and operational performance for the period would need to consult the referenced press release.

Key Highlights

  • 1Biogen Idec reported its full year and fourth quarter 2010 results of operations and financial condition via a press release on February 1, 2011.
  • 2The 8-K filing serves as a notification and incorporation by reference of this press release.
  • 3Investors can access the detailed financial and operational performance for the period ending December 31, 2010, through the furnished press release.
  • 4This filing follows standard SEC reporting procedures for earnings announcements.
  • 5The report does not contain new, material financial statements directly within the 8-K form itself but relies on the external press release.

Frequently Asked Questions

The primary purpose of this Form 8-K filing is to announce and furnish Biogen Idec's press release detailing its financial results and operations for the full year and the three months ended December 31, 2010. It serves as a notification to investors and the public about the company's performance during that period.

The specific financial results for the fourth quarter and full year ended December 31, 2010, are contained within the press release that Biogen Idec issued on February 1, 2011. This press release is furnished as Exhibit 99 to this 8-K filing and is incorporated by reference.

No, this Form 8-K filing does not include detailed financial statements directly within the report itself. It references a separate press release (Exhibit 99) which contains the comprehensive financial and operational results for the period.

For investors, this filing signifies that Biogen Idec has disclosed its recent financial performance. Investors should review the referenced press release to understand the company's revenue, profitability, and any significant business updates or outlook provided for the covered periods.